Trial
NCT05911308
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
AstraZeneca; Rgenix, Inc.
Condition
Non-Small Cell Lung Cancer
Intervention
Durvalumab
Why stopped
Sponsor is closing the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-21